Table 1.
Use of Sepsis Definitions in Different Regions and Hospital Sizes and Types
| No. of Hospitals | Sepsis-1 Used | Sepsis-3 Used | Sepsis-1 and Sepsis-3 Used | Any Other Definition or No Definition Used | |
|---|---|---|---|---|---|
| All hospitals | 1,023 | 24.5% (21.9%–27.3%) | 45.4% (42.3%–48.5%) | 23.2% (20.6%–25.9%) | 6.9% (5.5%–8.7%) |
| Region | |||||
| Northern Europe | 100 | 18.0% (11.0%–26.9%) | 48.0% (37.9%–58.2%) | 10.0% (4.9%–17.6%) | 24.0% (16.0%–33.6%) |
| Eastern Europe | 215 | 37.7% (31.2%–44.5%) | 39.5% (33.0%–46.4%) | 17.2% (12.4%–22.9%) | 5.6% (2.9%–9.5%) |
| Southern Europe | 185 | 22.7% (16.9%–29.4%) | 53.5% (46.0%–60.9%) | 20.0% (14.5%–26.5%) | 3.8% (1.5%–7.6%) |
| Western Europe | 335 | 18.2% (14.2%–22.8%) | 43.0% (37.6%–48.5%) | 33.4% (28.4%–38.8%) | 5.4% (3.2%–8.4%) |
| Other regions | 188 | 26.1% (19.9%–33.0%) | 46.8% (39.5%–54.2%) | 21.8% (16.1%–28.4%) | 5.3% (2.6%–9.6%) |
| Hospital size | |||||
| 0–250 beds | 295 | 29.8% (24.7%–35.4%) | 40.7% (35.0%–46.5%) | 24.4% (19.6%–29.7%) | 5.1% (2.9%–8.2%) |
| 251–500 beds | 298 | 25.8% (21.0%–31.2%) | 43.0% (37.3%–48.8%) | 22.8% (18.2%–28.0%) | 8.4% (5.5%–12.1%) |
| 501–750 beds | 157 | 22.3% (16.0%–29.6%) | 47.1% (39.1%–55.2%) | 22.3% (16.0%–29.6%) | 8.3% (4.5%–13.7%) |
| 751–1,000 beds | 133 | 17.3% (11.3%–24.8%) | 54.1% (45.3%–62.8%) | 21.8% (15.1%–29.8%) | 6.8% (3.1%–12.5%) |
| >1,000 beds | 140 | 20.0% (13.7%–27.6%) | 50.0% (41.4%–58.6%) | 23.6% (16.8%–31.5%) | 6.4% (3.0%–11.9%) |
| Hospital type | |||||
| General hospitals | 578 | 27.7% (24.1%–31.5%) | 42.0% (38.0%–46.2%) | 23.0% (19.6%–26.7%) | 7.3% (5.3%–9.7%) |
| University hospitals | 365 | 19.5% (15.5%–23.9%) | 51.0% (45.7%–56.2%) | 22.7% (18.5%–27.4%) | 6.8% (4.5%–9.9%) |
| Independent hospitals | 80 | 25.0% (16.0%–35.9%) | 43.8% (32.7%–55.3%) | 26.3% (17.0%–37.3%) | 5.0% (1.4%–12.3%) |
Data in parentheses are 95% CIs. “Sepsis-1” refers to the systemic inflammatory response syndrome criteria due to infection. “Sepsis-3” refers to new organ failure as evidenced by an increase in Sequential Organ Failure Assessment score by ≥2 due to infection.